Aileen Wang
Director of Finance/CFO bei CLOVER BIOPHARMACEUTICALS, LTD.
Profil
Aileen Wang is currently the Chief Financial Officer at Clover Biopharmaceuticals Ltd.
She previously worked at Novartis Gene Therapies, Inc. as the Head-Core Business Planning & Analysis.
Ms. Wang holds an MBA from The Pennsylvania State University and an undergraduate degree from Shanghai Jiao Tong University.
Aktive Positionen von Aileen Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director of Finance/CFO | 01.07.2022 |
Ehemalige bekannte Positionen von Aileen Wang
| Unternehmen | Position | Ende |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - |
Ausbildung von Aileen Wang
| The Pennsylvania State University | Masters Business Admin |
| Shanghai Jiao Tong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
